Personalizing Cancer Drugs Market Report

Global and Region Personalizing Cancer Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：171
  • REPORT CODE：GMM914566
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Personalizing Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Personalizing Cancer Drugsmarket, defines the market attractiveness level of Personalizing Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Personalizing Cancer Drugs industry, describes the types of Personalizing Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Personalizing Cancer Drugs market and the development prospects and opportunities of Personalizing Cancer Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Personalizing Cancer Drugs market in Chapter 13.

    By Player:

    • Hoffmann-La Roche

    • Bayer

    • Novartis

    • Teva Pharmaceuticals

    • Sanofi

    • Bristol-Myers Squibb

    • GlaxoSmithKline

    • Pfizer

    • Eli Lilly

    • Boehringer Ingelheim

    • Johnson and Johnson

    • Ariad Pharmaceuticals

    • Amgen

    • Celgene Corporation

    • Merck

    By Type:

    • Immunotherapy

    • Targeted Therapy

    • Chemotherapy

    • Hormone Therapy

    • Others

    By End-User:

    • Breast Cancer

    • Blood Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Skin Cancer

    • Lung Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Personalizing Cancer Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Personalizing Cancer Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Personalizing Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Personalizing Cancer Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Personalizing Cancer Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.2 United States Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.3 Europe Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.4 China Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.5 Japan Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.6 India Personalizing Cancer Drugs Consumption (2017-2022)

    • 7.7 South Korea Personalizing Cancer Drugs Consumption (2017-2022)

    8 Region and Country-wise Personalizing Cancer Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.4 China Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.6 India Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Personalizing Cancer Drugs Consumption Forecast (2022-2028)

    9 Global Personalizing Cancer Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Personalizing Cancer Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hormone Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personalizing Cancer Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Skin Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Personalizing Cancer Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Personalizing Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Personalizing Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Personalizing Cancer Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Personalizing Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Personalizing Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Personalizing Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Personalizing Cancer Drugs Market Competitive Analysis

    • 14.1 Hoffmann-La Roche

      • 14.1.1 Hoffmann-La Roche Company Details

      • 14.1.2 Hoffmann-La Roche Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Hoffmann-La Roche Personalizing Cancer Drugs Product and Service

    • 14.2 Bayer

      • 14.2.1 Bayer Company Details

      • 14.2.2 Bayer Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer Personalizing Cancer Drugs Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Personalizing Cancer Drugs Product and Service

    • 14.4 Teva Pharmaceuticals

      • 14.4.1 Teva Pharmaceuticals Company Details

      • 14.4.2 Teva Pharmaceuticals Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Teva Pharmaceuticals Personalizing Cancer Drugs Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Personalizing Cancer Drugs Product and Service

    • 14.6 Bristol-Myers Squibb

      • 14.6.1 Bristol-Myers Squibb Company Details

      • 14.6.2 Bristol-Myers Squibb Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bristol-Myers Squibb Personalizing Cancer Drugs Product and Service

    • 14.7 GlaxoSmithKline

      • 14.7.1 GlaxoSmithKline Company Details

      • 14.7.2 GlaxoSmithKline Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Personalizing Cancer Drugs Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Personalizing Cancer Drugs Product and Service

    • 14.9 Eli Lilly

      • 14.9.1 Eli Lilly Company Details

      • 14.9.2 Eli Lilly Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly Personalizing Cancer Drugs Product and Service

    • 14.10 Boehringer Ingelheim

      • 14.10.1 Boehringer Ingelheim Company Details

      • 14.10.2 Boehringer Ingelheim Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Boehringer Ingelheim Personalizing Cancer Drugs Product and Service

    • 14.11 Johnson and Johnson

      • 14.11.1 Johnson and Johnson Company Details

      • 14.11.2 Johnson and Johnson Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Johnson and Johnson Personalizing Cancer Drugs Product and Service

    • 14.12 Ariad Pharmaceuticals

      • 14.12.1 Ariad Pharmaceuticals Company Details

      • 14.12.2 Ariad Pharmaceuticals Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Ariad Pharmaceuticals Personalizing Cancer Drugs Product and Service

    • 14.13 Amgen

      • 14.13.1 Amgen Company Details

      • 14.13.2 Amgen Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Amgen Personalizing Cancer Drugs Product and Service

    • 14.14 Celgene Corporation

      • 14.14.1 Celgene Corporation Company Details

      • 14.14.2 Celgene Corporation Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Celgene Corporation Personalizing Cancer Drugs Product and Service

    • 14.15 Merck

      • 14.15.1 Merck Company Details

      • 14.15.2 Merck Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Merck Personalizing Cancer Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Personalizing Cancer Drugs

    • Figure Personalizing Cancer Drugs Picture

    • Table Global Personalizing Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalizing Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalizing Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Personalizing Cancer Drugs Consumption by Country (2017-2022)

    • Figure United States Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personalizing Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Personalizing Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personalizing Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Personalizing Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Personalizing Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Personalizing Cancer Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Personalizing Cancer Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Personalizing Cancer Drugs Product and Service

    • Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Personalizing Cancer Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Personalizing Cancer Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Personalizing Cancer Drugs Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Personalizing Cancer Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Personalizing Cancer Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Personalizing Cancer Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Personalizing Cancer Drugs Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Personalizing Cancer Drugs Product and Service

    • Table Ariad Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ariad Pharmaceuticals Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ariad Pharmaceuticals Personalizing Cancer Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Personalizing Cancer Drugs Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Personalizing Cancer Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Personalizing Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Personalizing Cancer Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US